Stay updated on MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial
Sign up to get notified when there's something new on the MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial page.

Latest updates to the MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study has transitioned from a Phase 1/2 to a Phase 1 study, with a new start date of May 6, 2025, and a reduction in the number of locations from 21 to 24. Additionally, the sponsor has changed from Mirati Therapeutics Inc. to Bristol-Myers Squibb.SummaryDifference14%
- Check19 days agoChange DetectedThe web page has been updated to a new version, v2.15.2, replacing the previous version v2.15.0.SummaryDifference0.2%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed descriptions of a clinical trial for MRTX1719 and the addition of new identifiers and conditions related to the study.SummaryDifference17%
- Check41 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check48 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check55 days agoChange DetectedDifference0.4%
Stay in the know with updates to MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial page.